The FMI Study titled “Breast Pump Market – Global Industry Analysis 2012–2016 and Opportunity Assessment 2016–2026”, highlights the potential factors fuelling the revenue growth of the breast pump market globally.

A breast pump is a medical device used to elicit breast milk from lactating women. Breast pump products are available in two models, including manual breast pumps and electrical breast pumps.

Electric breast pumps are available in two formats: single electric breast pumps and double electric breast pumps.

This report analyzes total revenue generated through sales of breast pump products, which include manual breast pumps and electric breast pump devices for breast feeding.

Breast pump products are increasingly becoming a necessity among working women across the world as the inclusion of women in workforce is increasing globally.

Since the last few years, the percentage of working women in workplaces across the globe has been declining (46.2% in 2019 as compared to 50.9% in 1990 as per “Catalyst”).

Emerging economies are witnessing impressive growth in healthcare spending. This can be attributed to improvements in healthcare technology and changing lifestyle, which is fuelling the demand for breast pumps among urban women.

According to WHO, the global healthcare spending rose by 2.4% in 2014 over 2013. Healthcare spending is growing at a rate of 5% in developing regions.

Rise in healthcare expenditure is expected to boost overall adoption of breast pumps among women, especially in Asia Pacific. Breast pump adoption is as high as 85% among breast feeding women at 3 months post-birth.

Furthermore, marketplace discussions indicate that the availability of breast pump accessory products will also encourage the adoption of electric breast pumps in developed markets.

In this regard, infant product manufacturers are increasingly bundling other pump-related products, such as nursing bras and breast pumping bras, to sell complete package of breast pumps, which is anytime more profitable than isolated sales.

Electrical breast pump packages find more adoption than manual breast pump products due to better volume of output.

These innovative solutions are projected to fuel breast pump market revenues in the global electric breast pumps market during the forecast period.

 https://www.futuremarketinsights.com/reports/sample/rep-gb-967

Koninklijke Philips N.V., Pigeon Corporation, Newell Brands, Medela Inc., Ameda Inc., Hygeia II Medical Group Inc., Bailey Medical, Mayborn Group Ltd. and Linco Baby Merchandise Works Co., Ltd.

The Electric breast pump market is more technologically advanced with higher product pricing and low penetration.

This category of breast pump comprises few global breast pump manufacturing companies.

Potential new entrants in breast pump market are trying to capture and improve their market position by using innovative marketing strategies, such as inorganic growth. Breast pump manufacturers are expanding their product portfolio using latest technologies.

Availability of BPA free breast pump products is fuelling breast pump adoption in developed as well as more the affluent markets in developing regions.

In the recent past, breast pump manufacturers have begun offering bisphenol A or BPA-free breast pump products to increase sales.

BPA is a chemical used to make milk container or feeding bottle rigid and more resistant and has been associated with adverse health effects, such as neural and fertility issues.

Examples of some BPA free breast pump products are Philips Avent Manual Comfort Breast Pump from Koninklijke Philips N.V. and BPA-free breast pumps by Medela, Inc.

Rapid rise in promotional/supporting campaigns for Breast Pump products is fuelling revenue growth of the breast pump market.

In November 2012, leading breast pump manufacturer Medela launched a campaign titled ‘Virtual Human Milk Collection Campaign’ to commemorate Prematurity Awareness Month, where the breast pump manufacturer encouraged and demonstrated the importance of breast milk for infants and babies.

Medela has also donated US$ 30,000 worth of breastfeeding related products to various neonatal intensive care units across the U.S.

Some of the leading breast pump manufacturing companies analyzed in the report include Koninklijke Philips N.V., Pigeon Corporation, Newell Brands, Medela Inc., Ameda Inc., Hygeia II Medical Group Inc., Bailey Medical, Mayborn Group Ltd. and   Linco Baby Merchandise Works Co., Ltd.

Ask from Market Research Expert @ 

 https://www.futuremarketinsights.com/ask-question/rep-gb-967

Open System Breast Pumps Closed System Breast Pumps

homecare settings healthcare facilities For in-depth insights, Download a PDF Brochure @   https://www.futuremarketinsights.com/reports/brochure/rep-gb-967

North America Latin America Western Europe Eastern Europe Japan Asia Pacific Excluding Japan (APEJ) the Middle East & Africa (MEA).

About Future Market Insights (FMI) Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years

Future Market Insights Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A

LinkedIn| Twitter| Blogs

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Copyright © 2022 PHARMIWEB.COM LIMITED, rights reserved by the relevant holders.

You are leaving PharmiWeb.com

Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites.

ABOUT THIRD PARTY LINKS ON OUR SITE

PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave the PharmiWeb.com website and will be redirected to another site. These sites are not under the control of PharmiWeb.com.

PharmiWeb.com is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information.

Also, please be aware that the security and privacy policies on these sites may be different than PharmiWeb.com policies, so please read third party privacy and security policies closely.

If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.